12 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/4/26 21:35
2/2/26
NTRAHealthHealthMedical LaboratoriesMoshkevich SolomonTXOP,CLINIC7S.dm-9,805154.720-63145D
2/4/26 21:35
2/2/26
NTRAHealthHealthMedical LaboratoriesChapman Steven LeonardTXDOCEO,P6S.dm-41,384228.450-181219D
2/4/26 21:35
2/3/26
NTRAHealthHealthMedical LaboratoriesBrophy Michael BurkesTXOCFO4S.dm-17,411233.240-7564D
2/4/26 21:05
2/3/26
NTRAHealthHealthMedical LaboratoriesFesko JohnTXOP,CHIEF 3S.m-5,499234.480-23178D
2/4/26 21:05
2/3/26
NTRAHealthHealthMedical LaboratoriesSheena JonathanTXDHCO-FOUND10S.dm-6,65193.180-71309D
2/4/26 21:05
2/3/26
NTRAHealthHealthMedical LaboratoriesRabinowitz DanielTXOSEC.,GC5S.dm-5,512179.850-31227D
12/16/25 21:05
12/12/25
NTRAHealthHealthMedical LaboratoriesRosenman HermTXD1S-11,011227.420-4820D
12/9/25 20:35
12/5/25
NTRAHealthHealthMedical LaboratoriesChapman Rowan ETXD2M.d1,190142.24086D
12/9/25 20:35
12/5/25
NTRAHealthHealthMedical LaboratoriesChapman Rowan ETXD2S.d-1,190142.240-86D
11/26/25 17:00
11/24/25
NTRAHealthHealthMedical LaboratoriesBotha RoelofCAD1S-17,709236.120-751,157I
11/21/25 20:05
11/19/25
NTRAHealthHealthMedical LaboratoriesBaynes Roy D.TXD2M.dm3,335130.4602618D
11/21/25 20:05
11/19/25
NTRAHealthHealthMedical LaboratoriesBaynes Roy D.TXD2S.dm-3,335130.460-2618D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact